Blastomyces dermatitidis Gilchrist et Stokes, anamorph
Strain Designations
CDC B-832 [NIH 6071]
Alternate State
Ajellomyces dermatitidis McDonough et Lewis
Application
Biomedical Research and Development Material
Emerging infectious disease research
Biosafety Level
3
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
frozen
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Type Strain
no
Antigenic Properties
serotype 2, serotype 2
RefKaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760
Preceptrol®
no
Medium
ATCC® Medium 336: Potato dextrose agar (PDA)
Growth Conditions
Temperature: 26.0°C
Name of Depositor
CDC
Chain of Custody
ATCC <<--CDC<<--H.F. Hasenclever NIH 6071 <<--- M.H. King
Isolation
human, Uganda
References
Kaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760
Kaufman L, et al. Detection of two Blastomyces dermatitidis serotypes by exoantigen analysis. J. Clin. Microbiol. 18: 110-114, 1983. PubMed: 6411760